Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-07-12
2005-07-12
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S227500, C514S227800, C514S283000, C514S318000, C514S319000, C514S321000, C514S330000, C544S059000, C544S060000, C546S048000, C546S238000, C546S263000
Reexamination Certificate
active
06916800
ABSTRACT:
The present invention provides methods to treat or prevent neoplasia disorders in a mammal using a combination of a matrix metalloproteinase inhibitor and an antineoplastic agent.
REFERENCES:
Che,ical abstract 128:12465, also cited as Relias et al in J. Oncology Pharm. Practice 3-4, 173-185(1997).
Cunningham James J.
Gately Stephen T.
Gordon Gary
Koki Alane T.
Masferrer Jaime L.
Butterfield Garth
Patel Sudhaker B.
Pfizer Inc
Raymond Richard L.
Richardson Peter C.
LandOfFree
Combination therapy including a matrix metalloproteinase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination therapy including a matrix metalloproteinase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy including a matrix metalloproteinase... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3409102